Keyphrases
Diabetes
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Streptozotocin
100%
Diabetic Mouse Model
100%
Inosine
100%
Type I Diabetes
100%
Non-obese Diabetic Mice
100%
Pancreas
16%
Purine
16%
Diabetes Incidence
16%
Cytokine Profile
16%
Islet
16%
Islet Transplantation
16%
Anti-inflammatory Effect
16%
Hyperglycemia
8%
Oxidative Stress
8%
Murine Model
8%
Leukocytes
8%
Immunomodulator
8%
Preventive Treatment
8%
Adenosine
8%
Mode of Action
8%
Streptozotocin-induced Diabetes
8%
Anti-inflammatory Agents
8%
Graft Rejection
8%
Graft Survival
8%
Transplantation Model
8%
Transplant Recipients
8%
Leukocyte Infiltration
8%
Islet Graft
8%
Renal Capsule
8%
Pancreatic Islets
8%
Immune Infiltration
8%
Surviving Cells
8%
Anti-rejection Therapy
8%
Glucosuria
8%
Ketonuria
8%
Oxidative Stress Profile
8%
Medicine and Dentistry
Diabetes
100%
Diabetes Mellitus
100%
Insulin Dependent Diabetes Mellitus
100%
Streptozocin
100%
Low Drug Dose
100%
Inosine
100%
Oxidative Stress
16%
Leukocyte
16%
Cytokine
16%
Antiinflammatory Activity
16%
Purine
16%
Hyperglycemia
8%
Metabolite
8%
Immunomodulating Agent
8%
Streptozotocin-Induced Diabetes Mellitus
8%
Transplantation
8%
Antiinflammatory Agent
8%
Graft Rejection
8%
Pancreatic Islet
8%
Islet Transplantation
8%
Immune Cell Infiltration
8%
Adenosine
8%
Graft Survival
8%
Glucosuria
8%
Ketonuria
8%
Immunology and Microbiology
Mouse Model
100%
Low Drug Dose
100%
Nonobese Diabetic Mouse
100%
Pancreas
50%
Cytokine
50%
Leukocyte
50%
Oxidative Stress
50%
Antiinflammatory Activity
50%
Metabolite
25%
Immunomodulating Drugs
25%
Murine
25%
Islet Transplantation
25%
Immune Cell Infiltration
25%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Streptozotocin
100%
Insulin Dependent Diabetes Mellitus
100%
Inosine
100%
Nonobese Diabetic Mouse
100%
Cytokine
16%
Purine
16%
Antiinflammatory Activity
16%
Hyperglycemia
8%
Immunomodulating Agent
8%
Adenosine
8%
Streptozotocin-Induced Diabetes Mellitus
8%
Murine
8%
Antiinflammatory Agent
8%
Graft Rejection
8%
Ketonuria
8%
Glucosuria
8%